ImmunityBio, Inc. IBRX
At closeNov 12, 2026, 6:03 PM EST
After hours · Nov 12, 6:03 PM ET
- YTD
- +206.57%
- 1 year
- +194.66%
Discussion (3506)
Sign in to join the discussion
So tired of all the worrying about day prices and minute to minute I have owned shares for over 3 years have built my position up the 550,000 never sold 1 share stop trading
Paul C what does it matter 8.50 8.30 9 where will we be in 1-5 years
I think IBRX is being traded by algorithms by hedge funds and big money Wall Street same people that hold the shorts that are backed by Big Pharma. The price movements and the speed is not being created by retail investors or normal in house trading.
So So So tired of short talk short squeeze it's not happening and won't. The bulk of the short positions are held and backed by big Pharma. They wanted to bankrupt ImmunityBio or force a sale to shelve Anktiva and keep their poisons selling as long as possible and then and only then introduce Anktiva.
These companies are evil greedy POS companies that don't care about people.
Wake up ImmunityBio and Dr PSS are black balled by MSM, main stream media.
Cramer is owned by Wall Street and big pharma he is $$$$ slut. Merck owns him.
The hedge funds use him to manipulate stocks up or down, he does what he is told to do. No honor a liar propaganda spreading douche bag.
Cramer was confused because I am sure the caller lied and said he was asking about a different company and surprised him. I guarantee if you call and said you're calling about ImmunityBio you won't get through.
Cramer is a POS he is owned by Wall Street big money and big pharma. CNBC NBC taking in billions in big pharma ad $$$ Merck pays them a fortune advertising Keytruda. He does as told.
When we get full FDA for all bladder cancer and get it in Europe it will be the standard for the world. The sales just for bladder cancer will make ImmunityBio earnings positive. Soon we get lung pancreatic breast lymphoma treatment for Lymphopenia and eventually it will have approvals like Merck's Keytruda 20 plus indications, and it replaces Keytruda. Why? Because it works when Keytruda is failing. So that's the 2-5 year news and guess what ImmunityBio will be the largest bio pharmaceutical company in the world. IBRX WILL TRADE OVER $100 a share easily.
My bet is full FDA approval for papillary bladder cancer soon 30-45 and we are off to the races and shorting IBRX will be over.
